Because different subsets of CD4+ T cells and their functions determine the outcomes of mucosal barrier immunity, T-dependent B cell responses, and CD8+ T cell-mediated anti-tumor immunity, alterations in these cells contribute to hampering of anti-cancer responses in the elderly. This evidence concerns the gene CD8A and cancer.